Inspire Medical Systems, Inc. financial data

Symbol
INSP on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
5500 Wayzata Blvd, Suite 1600, Golden Valley, MN
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 812 % -4.61%
Quick Ratio 72.1 % +150%
Debt-to-equity 15.7 % +1.49%
Return On Equity -2.82 % +72.6%
Return On Assets 4.58 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30M shares +1.5%
Common Stock, Shares, Outstanding 30M shares +1.91%
Entity Public Float 9.35B USD +88.3%
Common Stock, Value, Issued 30K USD +3.45%
Weighted Average Number of Shares Outstanding, Basic 29.9M shares +1.75%
Weighted Average Number of Shares Outstanding, Diluted 30.6M shares +4.32%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 756M USD +32.5%
Research and Development Expense 115M USD +7.6%
General and Administrative Expense 130M USD +15.1%
Operating Income (Loss) 13.5M USD
Nonoperating Income (Expense) 23.6M USD +30.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 37.1M USD
Income Tax Expense (Benefit) 2.96M USD +231%
Net Income (Loss) Attributable to Parent 33M USD
Earnings Per Share, Basic 1.12 USD/shares
Earnings Per Share, Diluted 1.09 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 148M USD -55.3%
Accounts Receivable, after Allowance for Credit Loss, Current 89.7M USD +25.6%
Inventory, Net 67.4M USD +158%
Assets, Current 583M USD +2.27%
Property, Plant and Equipment, Net 67.4M USD +109%
Operating Lease, Right-of-Use Asset 21.8M USD -5.5%
Other Assets, Noncurrent 11M USD -5.35%
Assets 796M USD +24.5%
Accrued Liabilities, Current 39.3M USD +31.3%
Liabilities, Current 74.3M USD +6.1%
Operating Lease, Liability, Noncurrent 25.2M USD +0.18%
Other Liabilities, Noncurrent 150K USD +2.74%
Liabilities 99.6M USD +4.53%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.7M USD +3764%
Retained Earnings (Accumulated Deficit) -327M USD +9.18%
Stockholders' Equity Attributable to Parent 697M USD +28%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 589M USD +16.7%
Liabilities and Equity 796M USD +24.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 8.86M USD
Net Cash Provided by (Used in) Financing Activities 768K USD -86.4%
Net Cash Provided by (Used in) Investing Activities -19.5M USD -421%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 30M shares +1.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.1M USD -1974%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 148M USD -55.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 117M USD +12.4%
Deferred Tax Assets, Gross 123M USD +15.9%
Operating Lease, Liability 25.3M USD +0.61%
Payments to Acquire Property, Plant, and Equipment 11.7M USD +212%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 34.7M USD
Lessee, Operating Lease, Liability, to be Paid 35.1M USD +242%
Property, Plant and Equipment, Gross 78.8M USD +101%
Operating Lease, Liability, Current 109K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.06M USD +67%
Lessee, Operating Lease, Liability, to be Paid, Year One 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.2M USD +631%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.31M USD +75.8%
Deferred Tax Assets, Operating Loss Carryforwards 57.3M USD -11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 100K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.42M USD +76%
Operating Lease, Payments 2.6M USD +85.7%
Additional Paid in Capital 1.02B USD +13%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 839K USD +41.5%
Share-based Payment Arrangement, Expense 29.9M USD +86.1%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%